Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Antiandrogens  COVID-19 treatment studies for Antiandrogens  C19 studies: Antiandrogens  Antiandrogens   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Apalutamide Prevents SARS-CoV-2 Infection in Lung Epithelial Cells and in Human Nasal Epithelial Cells
Majidipur et al., International Journal of Molecular Sciences, doi:10.3390/ijms24043288 (In Vitro)
Majidipur et al., Apalutamide Prevents SARS-CoV-2 Infection in Lung Epithelial Cells and in Human Nasal Epithelial Cells, International Journal of Molecular Sciences, doi:10.3390/ijms24043288 (In Vitro)
Feb 2023   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
In Vitro study showing that TMPRSS2 expression is regulated by androgens in Calu-3 cells, and treatment with anti-androgen drugs such as apalutamide significantly reduced SARS-CoV-2 entry and infection in both Calu-3 lung cells and primary human nasal epithelial cells.
Majidipur et al., 7 Feb 2023, France, peer-reviewed, 20 authors.
Contact: virginie.firlej@u-pec.fr (corresponding author).
In Vitro studies are an important part of preclinical research, however results may be very different in vivo.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperAntiandrogensAll
Abstract: International Journal of Molecular Sciences Article Apalutamide Prevents SARS-CoV-2 Infection in Lung Epithelial Cells and in Human Nasal Epithelial Cells Amene Majidipur 1 , Margot Morin-Dewaele 2, Jeanne Gaspar Lopes 1, Francois Berry 2, Julien Fouchet 1, Sophie Bartier 3,4,5, Anais Dufros Duval 1, Pascale Soyeux 1, Eric Huet 1 , Bruno Louis 5, André Coste 3,4,5, Émilie Béquignon 3,4,5 , Carolina Saldana 1,6, Philippe Le Corvoisier 7, Damien Destouches 1 , Jean-Michel Pawlotsky 2,8, Alexandre de la Taille 1,6,9, Francis Vacherot 1, Patrice Bruscella 2,† and Virginie Firlej 1,*,† 1 2 3 4 5 6 7 8 9 * † Citation: Majidipur, A.; MorinDewaele, M.; Gaspar Lopes, J.; Berry, F.; Fouchet, J.; Bartier, S.; Dufros Duval, A.; Soyeux, P.; Huet, E.; Louis, B.; et al. Apalutamide Prevents SARS-CoV-2 Infection in Lung Epithelial Cells and in Human Nasal Epithelial Cells. Int. J. Mol. Sci. 2023, 24, 3288. https://doi.org/10.3390/ ijms24043288 Academic Editor: Francesco B. Blasi Received: 5 December 2022 TRePCa, Université Paris Est Créteil, F-94010 Créteil, France Team “Viruses, Hepatology, Cancer”, Institut Mondor de Recherche Biomédicale, Université Paris Est Créteil, INSERM U955, F-94010 Créteil, France Department of ENT and Head and Neck Surgery, Centre Hospitalier Intercommunal de Créteil, F-94010 Créteil, France AP-HP, Department of ENT and Head and Neck Surgery, Centre Hospitalier Universitaire Henri Mondor, F-94010 Créteil, France Team “Biomechanics and Respiratory System“, Institut Mondor de Recherche Biomédicale, Université Paris Est Créteil, INSERM U955, CNRS EMR 7000, F-94010 Créteil, France AP-HP, Department of Oncology, Centre Hospitalier Universitaire Henri Mondor, F-94010 Créteil, France INSERM, AP-HP, Clinical Investigation Center 1430, Henri Mondor University Hospital, F-94000 Créteil, France AP-HP, Department of Virology, Centre Hospitalier Universitaire Henri Mondor, F-94010 Créteil, France AP-HP, Department of Urology, Centre Hospitalier Universitaire Henri Mondor, F-94010 Créteil, France Correspondence: virginie.firlej@u-pec.fr; Tel.: +33-1-49-81-36-14 These authors contributed equally to this work. Abstract: In early 2020, the novel pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, and rapidly propagated worldwide causing a global health emergency. SARS-CoV-2 binds to the angiotensin-converting enzyme 2 (ACE2) protein for cell entry, followed by proteolytic cleavage of the Spike (S) protein by the transmembrane serine protease 2 (TMPRSS2), allowing fusion of the viral and cellular membranes. Interestingly, TMPRSS2 is a key regulator in prostate cancer (PCa) progression which is regulated by androgen receptor (AR) signaling. Our hypothesis is that the AR signaling may regulate the expression of TMPRSS2 in human respiratory cells and thus influence the membrane fusion entry pathway of SARS-CoV-2. We show here that TMPRSS2 and AR are expressed in Calu-3 lung cells. In this cell line, TMPRSS2 expression is regulated by androgens. Finally, pre-treatment with anti-androgen drugs such as apalutamide significantly reduced SARS-CoV-2 entry and infection in Calu-3 lung cells but also in primary human nasal epithelial cells. Altogether, these data provide strong evidence to support the use of apalutamide as a treatment option for the PCa population vulnerable to severe COVID-19. Keywords: SARS-CoV-2; androgen; ARPI; TMPRSS2 Revised: 29 January 2023 Accepted: 2 February..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit